{"symbol":"JNJ","fiscalQuarter":"Q2-2025","reportDate":"2025-07-16","reportTime":"BMO","status":"reported","company":{"name":"Johnson & Johnson","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/JNJ/earnings/Q2-2025","postBrief":{"headline":"Johnson & Johnson Beats on EPS, Stock Up 6.19%","keyNumbers":[{"metric":"EPS","actual":"$2.77","expected":"N/A","surprise":"+4.53%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We are pleased with our EPS performance this quarter.","Our focus remains on innovation and maintaining strong operational efficiency."],"summary":"Management expressed satisfaction with the EPS results, highlighting ongoing efforts in innovation. They emphasized a commitment to operational efficiency moving forward."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"This earnings report indicates that Johnson & Johnson is performing well in terms of earnings per share, which exceeded expectations. The stock rose by 6.19% following the announcement, reflecting investor confidence in the company's ability to generate profits. However, the lack of revenue figures and guidance leaves some uncertainty about future performance.","metaDescription":"Johnson & Johnson (JNJ) Q2 2025 earnings: EPS beat by 4.53%. Stock up 6.19%. Full breakdown."}}